These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 18059124)
21. In vitro monitoring of Plasmodium falciparum susceptibility to artesunate, mefloquine, quinine and chloroquine in Cambodia: 2001-2002. Lim P; Chim P; Sem R; Nemh S; Poravuth Y; Lim C; Seila S; Tsuyuoka R; Denis MB; Socheat D; Fandeur T Acta Trop; 2005 Jan; 93(1):31-40. PubMed ID: 15589795 [TBL] [Abstract][Full Text] [Related]
22. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso. Tahita MC; Tinto H; Yarga S; Kazienga A; Traore Coulibaly M; Valea I; Van Overmeir C; Rosanas-Urgell A; Ouedraogo JB; Guiguemde RT; van Geertruyden JP; Erhart A; D'Alessandro U Malar J; 2015 Jun; 14():251. PubMed ID: 26088768 [TBL] [Abstract][Full Text] [Related]
23. Chloroquine-resistant Plasmodium falciparum local strain in Taiz Governorate, Republic of Yemen. Alkadi HO; Al-Maktari MT; Nooman MA Chemotherapy; 2006; 52(4):166-70. PubMed ID: 16720983 [TBL] [Abstract][Full Text] [Related]
24. In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Basco LK; Le Bras J Ann Trop Med Parasitol; 1994 Apr; 88(2):137-44. PubMed ID: 8067809 [TBL] [Abstract][Full Text] [Related]
25. High-throughput analysis of antimalarial susceptibility data by the WorldWide Antimalarial Resistance Network (WWARN) in vitro analysis and reporting tool. Woodrow CJ; Dahlström S; Cooksey R; Flegg JA; Le Nagard H; Mentré F; Murillo C; Ménard D; Nosten F; Sriprawat K; Musset L; Quashie NB; Lim P; Fairhurst RM; Nsobya SL; Sinou V; Noedl H; Pradines B; Johnson JD; Guerin PJ; Sibley CH; Le Bras J Antimicrob Agents Chemother; 2013 Jul; 57(7):3121-30. PubMed ID: 23612201 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of pyronaridine against Plasmodium falciparum and comparative evaluation of anti-malarial drug susceptibility assays. Kurth F; Pongratz P; Bélard S; Mordmüller B; Kremsner PG; Ramharter M Malar J; 2009 Apr; 8():79. PubMed ID: 19389221 [TBL] [Abstract][Full Text] [Related]
27. In vitro stage-specific sensitivity of Plasmodium falciparum to quinine and artemisinin drugs. Skinner TS; Manning LS; Johnston WA; Davis TM Int J Parasitol; 1996 May; 26(5):519-25. PubMed ID: 8818732 [TBL] [Abstract][Full Text] [Related]
28. In vitro susceptibility of Plasmodium falciparum to four antimalarial drugs in the Central Province of Papua New Guinea. Hombhanje FW P N G Med J; 1998 Jun; 41(2):51-8. PubMed ID: 10934544 [TBL] [Abstract][Full Text] [Related]
29. Agarwal P; Anvikar AR; Pillai CR; Srivastava K Indian J Med Res; 2017 Nov; 146(5):622-628. PubMed ID: 29512604 [TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Plasmodium falciparum in vitro to chloroquine, mefloquine, quinine and sulfadoxine/pyrimethamine in Somalia: relationships between the responses to the different drugs. Warsame M; Wernsdorfer WH; Payne D; Björkman A Trans R Soc Trop Med Hyg; 1991; 85(5):565-9. PubMed ID: 1780976 [TBL] [Abstract][Full Text] [Related]
31. In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum. Ndong JM; Atteke C; Aubouy A; Bakary M; Lébibi J; Deloron P Trop Med Int Health; 2003 Jan; 8(1):25-9. PubMed ID: 12535246 [TBL] [Abstract][Full Text] [Related]
32. In vitro antimalarial drug susceptibility in Thai border areas from 1998-2003. Chaijaroenkul W; Bangchang KN; Mungthin M; Ward SA Malar J; 2005 Aug; 4():37. PubMed ID: 16060967 [TBL] [Abstract][Full Text] [Related]
33. Sensitivity to antimalarial drugs by Plasmodium falciparum in Goundry, Oubritenga province, Burkina Faso. Del Nero L; Lamizana L; Pietra V; Nebié I Parassitologia; 1994 Dec; 36(3):287-93. PubMed ID: 7637999 [TBL] [Abstract][Full Text] [Related]
34. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea. Benito A; Roche J; Molina R; Amela C; Alvar J Am J Trop Med Hyg; 1995 Nov; 53(5):526-31. PubMed ID: 7485712 [TBL] [Abstract][Full Text] [Related]
35. Chloroquine-resistant Plasmodium falciparum with reduced sensitivity in vitro to mefloquine and quinine in Zaria, northern Nigeria. Lege-Oguntoye L; Abua JU; Werblinska B; Ogala WN; Slotboom AB; Olurinola PF J Trop Med Hyg; 1991 Apr; 94(2):73-5. PubMed ID: 2023291 [TBL] [Abstract][Full Text] [Related]
36. In vitro susceptibility of Tanzanian wild isolates of Plasmodium falciparum to artemisinin, chloroquine, sulfadoxine/pyrimethamine and mefloquine. Alin MH Parasitology; 1997 Jun; 114 ( Pt 6)():503-6. PubMed ID: 9172420 [TBL] [Abstract][Full Text] [Related]
37. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season. Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362 [TBL] [Abstract][Full Text] [Related]
38. In vitro activity of quinolines against Plasmodium falciparum in Gabon. Ramharter M; Wernsdorfer WH; Kremsner PG Acta Trop; 2004 Mar; 90(1):55-60. PubMed ID: 14739023 [TBL] [Abstract][Full Text] [Related]